Carvana CEO Garcia sells $3.6m in shares

Published 10/10/2025, 23:22
Carvana CEO Garcia sells $3.6m in shares

Carvana (NASDAQ:CVNA) Chief Executive Officer Ernest Garcia III indirectly sold a total of $3.6 million in Class A Common Stock on October 8, 2025. The sales occurred at prices ranging from $362.58 to $370.0, amid a period of significant growth for the company, which has seen its revenue increase by 39.5% over the last twelve months. According to InvestingPro data, Carvana’s stock has delivered an impressive 71.9% return over the past year, despite recent volatility.

The transactions involved the sale of shares held indirectly through the Ernest Irrevocable 2004 Trust III and the Ernest C. Garcia III Multi-Generational Trust III. Specifically, 459 shares were sold by the Ernest Irrevocable 2004 Trust III at $362.58, and 459 shares were sold by the Ernest C. Garcia III Multi-Generational Trust III at $362.58. Another 703 shares were sold by the Ernest Irrevocable 2004 Trust III at $363.26, and 702 shares were sold by the Ernest C. Garcia III Multi-Generational Trust III at $363.73. Additionally, 1094 shares were sold by the Ernest Irrevocable 2004 Trust III at $364.30, and 1094 shares were sold by the Ernest C. Garcia III Multi-Generational Trust III at $364.30. Furthermore, 671 shares were sold by the Ernest Irrevocable 2004 Trust III at $365.36, and 671 shares were sold by the Ernest C. Garcia III Multi-Generational Trust III at $365.36. 519 shares were sold by the Ernest Irrevocable 2004 Trust III at $366.42, and 519 shares were sold by the Ernest C. Garcia III Multi-Generational Trust III at $366.42. 670 shares were sold by the Ernest Irrevocable 2004 Trust III at $367.45, and 670 shares were sold by the Ernest C. Garcia III Multi-Generational Trust III at $367.45. 666 shares were sold by the Ernest Irrevocable 2004 Trust III at $368.50, and 666 shares were sold by the Ernest C. Garcia III Multi-Generational Trust III at $368.50. 163 shares were sold by the Ernest Irrevocable 2004 Trust III at $369.32, and 164 shares were sold by the Ernest C. Garcia III Multi-Generational Trust III at $369.59. Finally, 55 shares were sold by the Ernest Irrevocable 2004 Trust III at $370.00, and 55 shares were sold by the Ernest C. Garcia III Multi-Generational Trust III at $370.00.

Following these transactions, the Ernest Irrevocable 2004 Trust III and the Ernest C. Garcia III Multi-Generational Trust III indirectly hold 351440 and 451440 shares respectively. Mr. Garcia also directly holds 920696 shares.

The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 13, 2024. With the company’s next earnings report due on October 29, 2025, investors seeking deeper insights can access comprehensive analysis and Fair Value estimates through InvestingPro’s detailed research reports, which cover over 1,400 US stocks including Carvana .

In other recent news, Carvana has been the subject of multiple analyst updates and credit evaluations. Moody’s has upgraded Carvana’s corporate family rating to B2 from B3, highlighting improvements in the company’s operating performance and voluntary debt reduction, which have positively impacted its credit metrics. Additionally, Jefferies has upgraded Carvana’s stock rating from Hold to Buy, citing the company’s advantageous position in the growing digital used car market and raising the price target to $475.00. Meanwhile, BTIG has reiterated its Buy rating on Carvana, maintaining a $450.00 price target despite concerns over the company’s financing activities and credit exposure.

JPMorgan has also increased its price target for Carvana to $425.00, maintaining an Overweight rating based on solid fundamentals and recent strong second-quarter results. Citizens JMP has reiterated a Market Outperform rating with a $460.00 price target, supported by favorable industry trends that bolster the positive outlook for Carvana’s business. These developments reflect a range of perspectives from analysts and credit agencies, showcasing a generally optimistic view of Carvana’s financial health and market positioning.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.